Search the Newsreel

PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus

PRVA Q2 Deep Dive: Revenue Growth Outpaces Profit as Margin Expansion Remains in Focus Healthcare tech company Privia Health Group (NASDAQ:PRVA) beat Wall Street's revenue expectations in Q2 CY2026, with sales up 21.4% year on year to $632.6 million. Its non-GAAP profit of $0.19 …

Joby Aviation Establishes Texas Hub for Advanced Air Mobility Innovation

Joby Aviation has established a new 45,000-square-foot facility at Hillwood's Perot Field Fort Worth Alliance Airport, marking its first major presence in Texas for electric vertical takeoff and landing (eVTOL) aircraft companies. This new hub will support future electric air taxi operations across the …

Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc.

Harrow has entered into a definitive agreement to acquire Tyrvaya (varenicline solution), a dry eye nasal spray treatment, from Viatris Inc. This acquisition aims to expand Harrow's dry eye portfolio, complementing its Vevye franchise by offering a differentiated treatment option with a distinct mechanism …

Viasat and BMW Group Demonstrate Integrated Automotive Satellite Voice Capability Over L-Band Network

Viasat and BMW Group successfully demonstrated integrated automotive satellite voice capability over Viasat's L-band network using a BMW production vehicle platform. This technology allows for continuous operational connectivity for emergency assistance, telematics, and voice services in areas without terrestrial cellular signals, leveraging 3GPP standards. …

Privia Health Group Inc (PRVA) Stock Down 8.2% -- Now Undervalued? GF Score: 88/100

Privia Health Group Inc (PRVA) shares fell 8.2% to $22.00, but are considered undervalued by the GF Value™ estimate of $27.63, creating a 20.4% margin of safety. The company has a strong GF Score™ of 88/100, with high ratings for growth and valuation, despite …

Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ...

Viatris Inc (VTRS) reported strong Q2 2026 results with $3.8 billion in revenues, a 3.5% operational growth year-over-year, and raised its full-year guidance. Key drivers included robust performance in Greater China and advancements in its R&D pipeline. The company also highlighted challenges such as …

Also TM-B E-Bike Deliveries Begin: What Rivian Spinoff Buyers Should Know

Also TM-B E-Bike Deliveries Begin: What Rivian Spinoff Buyers Should Know Rivian's e-bike offshoot has finally started putting hardware on trucks. The interesting part of this story isn't the delay — it's what the company's own paperwork reveals about how it structured the deal …

Viavi Solutions (VIAV) Stock Climbs As Margin Turnaround Gains Credibility

Viavi Solutions (VIAV) stock rose after strong Q4 and FY26 earnings, suggesting a credible margin turnaround driven by a pivot to AI data center and aerospace and defense testing. The company reported significant increases in revenue, net income, EPS, and operating margins, with Spirent …

Get Paid by September 1st with These 4 Dividend Stocks. But There’s a Catch.

Quick Read Buy FTAI or WINA shares by August 11 to collect dividends of $0.50 and $1.02, as both stocks share an August 12 record date. FTAI raised its payout for the fourth straight quarter but cut EBITDA guidance by $100M while carrying $3.45B …

Viatris Inc. Stock 12‑Month Price Target Raised to $18.71, Implies 6% Upside

Viatris Inc. (VTRS) has seen its average 12-month price target raised from $18.14 to $18.71 by 7 analysts, suggesting a 6% potential upside from its August 5th closing price. The consensus analyst rating remains a "Buy," with 5 out of 12 analysts recommending a …

Why Joby Aviation Stock Flew Higher Today

It's been a difficult year for electric vertical takeoff and landing (eVTOL) company Joby Aviation (NYSE: JOBY), and despite today's more than 5% increase, the stock is still down more than 37% year to date. That said, the recent second-quarter results and news flow …

Viasat Inc 2Q 2026: Revenue $1.16B, EPS $(0.38) — 10-Q Summary

Viasat Inc. reported its second-quarter 2026 results, showing revenue of $1.1565 billion and a net loss of $51.7 million, with diluted loss per share improving to $(0.38) compared to the prior-year quarter. The company observed a shift towards recurring service revenues, growth in in-flight …

Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overvalued

Viatris Inc (VTRS) shares fell 7.6% to $16.29, which is still 47.7% above its GF Value of $11.03, indicating the stock is significantly overvalued. The company has a GF Score of 58/100, with weak growth potential, and recent insider selling further suggests a cautious …

Why Rivian's R2 EV could be its new star vehicle

Yahoo Finance Senior Autos Reporter Pras Subramanian explains what you need to know about Rivian's (RIVN) R2 electric vehicle (EV). Video Transcript 00:00 Speaker A At first blush exterior wise, it's hard to tell the difference between the R1 and the R2, with R1 …

Joby Aviation Stock Jumps as Air Taxi Launch Moves Closer

This article first appeared on GuruFocus. Joby Aviation (NYSE:JOBY) shares climbed about 7% on Thursday after the electric air taxi developer raised its full-year revenue outlook and highlighted progress toward commercial passenger operations. The stock gained as investors welcomed improved guidance, advancing FAA certification …

Archer Aviation (ACHR) Marks Two Milestones With ZEE AI Breakthrough And Midnight Flight

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Archer Aviation (NYSE:ACHR) reports a breakthrough ZEE AI foundation model for real time prediction of surface aircraft trajectories, aimed at supporting safer aviation and …

Viatris Inc. stock falls Thursday, underperforms market

Viatris Inc. (VTRS) stock fell 7.71% to $16.29 on Thursday, marking its second consecutive day of losses. This decline occurred during a broader market downturn, with the S&P 500 Index and Dow Jones Industrial Average also experiencing losses.

MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MetaVia Inc. announced its Q2 2026 financial results, highlighting progress in its clinical development programs for DA-1726 and vanoglipel. The company successfully reached the highest planned dose levels in its Phase 1 Part 3 study of DA-1726 for obesity, with 16-week topline data expected …

Earnings Flash (PRVA) Privia Health Group, Inc. Reports Q2 Revenue $632.6M, Vs. FactSet Est of $597.3M

Privia Health Group, Inc. (PRVA) announced its Q2 revenue of $632.6 million, significantly surpassing the FactSet estimate of $597.3 million. This indicates stronger-than-anticipated financial performance for the quarter.

Privia Health Group Inc (PRVA) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Privia Health Group Inc (NASDAQ:PRVA) delivered strong operational execution with implemented provider growth of 10.1% …

Why Are Zevia (NYSE:ZVIA) Shares Lower After Revenue Beat?

Viasat Advances Equatys D2D Joint Venture Toward Initial Constellation Procurement

Viasat's Direct-to-Device (D2D) joint venture with Space42, named Equatys, is progressing into its initial satellite procurement phase. The venture aims to establish a "Space TowerCo" model with up to 2,800 LEO satellites to provide direct connectivity to unmodified 5G smartphones and other devices, using …

Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth

Viatris, one of the largest generic drug manufacturers globally, aims for long-term growth through new product launches, pipeline progression, and cost savings. While generics face erosion in developed markets, the company plans to focus on complex generics to mitigate pricing and margin pressures. This …

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Viatris has agreed to sell its Tyrvaya nasal spray business to Harrow Inc. for up to $100 million, a move that will allow Viatris to focus on high-potential growth areas like complex generics and transdermal products, and continued investment in the Greater China market. …

Viatris Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VTRS) 2026-08-06

Rivian's R2 Launch Quarter Looks Great Until You Read The Segments

Rivian's R2 Launch Quarter Looks Great Until You Read The Segments Rivian's second quarter looks like a turning point if you read the top line and a warning if you read the middle. The top line is genuinely good. Revenue of $1.658 billion, up …

VIA TRANSPORTATION DEADLINE: ROSEN, A GLOBAL AND LEADING

The Rosen Law Firm is encouraging investors of Via Transportation, Inc. (NYSE: VIA) who experienced losses exceeding $100,000 to secure legal counsel before the August 10, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Via's IPO Offering Documents …

Rivian's R2 Is Shipping and Uber Wants 50,000 of Them

Key Points Rivian began delivering its R2 SUVs in June. Uber plans to buy up to 50,000 of those SUVs over the next few years.10 stocks we like better than Rivian Automotive › Rivian (NASDAQ: RIVN) started shipping its newest electric vehicle, the R2 …

Viasat Jumps 6.1% Amid Sector-Wide Rally

Viasat, Inc. saw its stock surge by 6.1% on Thursday, closing at $85.99, as it participated in a broad rally across communication equipment companies. This sector-wide movement, also affecting peers like LITE and VIAV, suggests a renewed investor interest in the space. Viasat's outperformance, …

Viatris stock hits 52-week high at 18.27 USD

Viatris Inc. (VTRS) stock reached a 52-week high of $18.07, demonstrating strong investor confidence with a 109.7% return over the past year and a market capitalization of $20.55 billion. InvestingPro analysis suggests the stock is undervalued with a "GOOD" financial health score. Recent positive …

IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies

By Exec Edge Editorial Staff IQVIA (NYSE: IQV) and clinical-stage biopharmaceutical company Medera Inc. announced a strategic collaboration aimed at accelerating the development of cardiac gene therapies and human-based drug discovery platforms. Under the partnership, Medera's Sardocor unit will use IQVIA's clinical trial, regulatory …

Chorus Aviation (TSX:CHR) Latest Results Challenge Current Market Expectations Again

Privia Health Group (NASDAQ:PRVA) Shares Gap Down - Should You Sell?

Privia Health Group Releases Q2 2026 Financial Results

Privia Health Group (PRVA) exceeded Q2 2026 earnings expectations, reporting adjusted EPS of $0.19 against a $0.07 estimate, and revenue of $632.6M, a 21.4% increase year-over-year. The company's growth was driven by its expanding provider network and value-based care arrangements, with full-year revenue guidance …

Three-quarters of drivers willing to pay for satellite-connected car services – report

A new study by Viasat and the 5G Automotive Association reveals that 75% of drivers are willing to pay for satellite-connected car services, largely due to frequently experiencing mobile signal 'dead zones'. Safety services, such as emergency calls and real-time hazard alerts, are the …

Rivian Automotive Stock Has Loaded Its Profit Case Into One Quarter